Investigating the impact of indoor tanning policies on skin cancer rates and economics
A Multi-Level Investigation of US Indoor Tanning PolicyEnactment, Implementation, Compliance, Impact, and Economics
This study looks at how rules about indoor tanning can help lower skin cancer rates, especially for young people who are more at risk, and it aims to find ways to encourage healthier choices among them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10874397 on NIH RePORTER |
What this research studies
This research examines how policies regulating indoor tanning can affect skin cancer rates and the economic implications of these regulations. It focuses on understanding the enactment, implementation, and compliance of these policies, particularly in relation to youth who are at higher risk for skin cancer due to indoor tanning. By analyzing data and conducting interviews, the research aims to identify effective strategies for reducing indoor tanning and its associated health risks. The findings could inform future health policies and promote better health behaviors among young people.
Who could benefit from this research
Good fit: Ideal candidates for this research are young individuals, particularly teenagers and young adults, who engage in indoor tanning or are at risk for skin cancer.
Not a fit: Patients who do not engage in indoor tanning or are not at risk for skin cancer may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective policies that significantly reduce the incidence of skin cancer among young people.
How similar studies have performed: Previous research has shown that stricter regulations on indoor tanning can lead to decreased usage among youth, indicating potential success for similar approaches.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Heckman, Carolyn — Rutgers Biomedical and Health Sciences
- Study coordinator: Heckman, Carolyn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.